AVENIO Millisect: payments to doctors
Payments that named AVENIO Millisect as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $12K
- Providers
- 7
- Transactions
- 10
- Average per transaction
- $1,187
The per-transaction average — $1,187 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7 providers the average total is $1,696, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Roche Diagnostics Corporation | $8,301 | 69.9% |
| Roche Sequencing Solutions, Inc. | $3,300 | 27.8% |
| Roche Molecular Systems, Inc. | $274 | 2.3% |